ArticleThe oncologist2021

Tumor Evolution in a Patient with Recurrent Endometrial Cancer and Synchronous Neuroendocrine Cancer and Response to Checkpoint Inhibitor Treatment.

Nikolaos A Trikalinos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.